ORI BIOTECH
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. Ori has developed a proprietary, flexible manufacturing platform that closes, automates, and standardizes manufacturing allowing therapeutics developers to further develop and bring their products from pre-clinical process development to commercial-scale manufacturing. The company aims to speed up the innovation of cell and gene therapies through the manufacturing platform it is bringing to market.
ORI BIOTECH
Industry:
Biotechnology Industrial Automation Manufacturing Therapeutics
Founded:
2015-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oribiotech.com
Total Employee:
11+
Status:
Active
Total Funding:
139.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Wordpress Plugins Sitelinks Search Box Euro Organization Schema Yoast WordPress SEO Plugin ReCAPTCHA
Similar Organizations
ANYbotics
ANYbotics is a robotics company that specializes in the development of advanced legged robots for industrial inspection.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
JW Therapeutics
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
Octopus Ventures
Octopus Ventures investment in Series B - Ori Biotech
Northpond Ventures
Northpond Ventures investment in Series B - Ori Biotech
Amadeus Capital Partners
Amadeus Capital Partners investment in Series B - Ori Biotech
Delin Ventures
Delin Ventures investment in Series B - Ori Biotech
Novalis LifeSciences
Novalis LifeSciences investment in Series B - Ori Biotech
Puhua Capital
Puhua Capital investment in Series B - Ori Biotech
Chimera Investment
Chimera Investment investment in Series B - Ori Biotech
Northpond Ventures
Northpond Ventures investment in Series A - Ori Biotech
Delin Ventures
Delin Ventures investment in Series A - Ori Biotech
Kindred Capital
Kindred Capital investment in Series A - Ori Biotech
Official Site Inspections
http://www.oribiotech.com
- Host name: rose-groovy-silverbirch.nh-serv.co.uk
- IP address: 93.114.235.210
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Ori Biotech"
Ori Biotech - Crunchbase Company Profile & Funding
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. Ori has developed a proprietary, flexible manufacturing platform that closes, automates, and standardizes …See details»
Ori Biotech - LinkedIn
Ori Biotech is a London- and Philadelphia-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables …See details»
Careers | Cell & Gene Therapy | Oribiotech Ltd
Oribiotech Ltd. CIC Philadelphia 3675 Market St, Suite 200 Philadelphia, PA 19204. London Biosciences Innovation Centre 2 Royal College Street London, NW1 0NH.See details»
Ori Biotech Company Profile 2024: Valuation, Funding …
Ori Biotech General Information Description. Developer of cell and gene therapy (CGT) manufacturing technology intended for flexible process discovery, translation, and scalable commercialization of cell and gene therapies.See details»
People and Culture - Oribiotech Ltd
Oribiotech Ltd. CIC Philadelphia 3675 Market St, Suite 200 Philadelphia, PA 19204. London Biosciences Innovation Centre 2 Royal College Street London, NW1 0NH.See details»
Ori Biotech, Charles River Cell Therapy Manufacturing Platform ...
Sep 24, 2024 Ori Biotech, a manufacturing technology company with hubs in London and Philadelphia, and Charles River Laboratories, headquartered in Wilmington, Mass., jointly …See details»
Ori is courting big-name clients with its production tech - Fierce …
Sep 13, 2022 The company's platform—which seeks to simplify the cell and gene therapy manufacturing odyssey—is propped up by three main pillars, the company’s CEO Jason …See details»
Ori Biotech raises over $100 million in Series B funding …
Jan 18, 2022 For more information, visit oribiotech.com. About Novalis LifeSciences Novalis LifeSciences is a boutique investment and advisory firm for the Life Science industry that was founded in 2017 by ...See details»
Ori Biotech Unveils IRO Platform at Annual International Society …
May 29, 2024 Innovative cell therapy manufacturing platform moving industry toward widespread patient access to life-saving cell and gene therapiesLONDON, May 29, 2024 (GLOBE …See details»
Ori reveals automated cell therapy production platform …
May 29, 2024 Ori estimates that more than 95% of patients who could benefit from a cell or gene therapy are left without access thanks to common production hurdles related in large part to scalability and cost.See details»
Ori Biotech and CTMC partner to accelerate novel cell therapy …
Sep 13, 2022 London, UK, and Houston, TX, US, September 13, 2022 – Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing technologies, and the Cell Therapy …See details»
Ori Biotech and CTMC Present Scientific Data for New IRO®
Jun 3, 2024 Ori LEAP partner CTMC shares biological results demonstrating new manufacturing platform can accelerate cell and gene therapy development. June 03, 2024 09:30 ET | Source: …See details»
Ori Biotech Is Designing Modules for Scalable Cell Therapy …
Dec 14, 2023 Ori Biotech has three major pillars: biological characterization, automation engineering, and data collection, analysis, and implementation.See details»
Ori Biotech reaps $100M in series B round to help launch …
Jan 18, 2022 Ori Biotech, which is on the cusp of launching an innovative process for manufacturing cell and gene therapies (CGTs), tallied more than $100 million in its latest …See details»
Ori Biotech adds to senior team, Scientific Advisory Board and …
London, UK, August 30, 2022 – Ori Biotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, today announces details of its strategic expansion plan following its …See details»
Ori Biotech: Revolutionising cell and gene therapy ... - PA Consulting
Cell and gene therapies (CGT) represent a significant breakthrough in the treatment of patients suffering from cancer and rare diseases. Ori Biotech, a London and Philadelphia-based …See details»
Ori Biotech and Charles River Laboratories Collaborate to
PHILADELPHIA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ori Biotech (Ori), a leader in cell and gene therapy (CGT) manufacturing enabling technology, and Charles River Laboratories …See details»
Ori Biotech Wins 2024 Biotech Breakthrough CGT Innovation Award
The BioTech Breakthrough Awards, organized by Tech Breakthrough, is an independent market intelligence organization celebrating the top companies, products, and services driving …See details»
News - Ori Biotech
Ori Biotech LTD. CIC Philadelphia 3675 Market St, Suite 200 Philadelphia, PA 19204. London Biosciences Innovation Centre 2 Royal College Street London, NW1 0NHSee details»